ArticleAmerican journal of translational research2025
Early identification of fetal growth restriction using ultrasound biometrics and biochemical markers: a comprehensive diagnostic approach.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate whether ultrasound biometrics improve the identification and early treatment of fetal growth restriction (FGR).
methodsThis retrospective study analyzed 240 pregnant women admitted to a Ji'nan Maternity and Child Care Hospital over a five-year period starting from January 2021. The study population comprised 120 women with fetal growth restriction (FGR group) and 120 women with normal pregnancies (Control group). The diagnosis of FGR was based on ultrasound measurements, with estimated fetal weight (EFW) and abdominal circumference (AC) both below the 10th percentile. Clinical data on, including maternal risk factors, ultrasound scans, and fetal data (e.g., weight, health status, ultrasound measurements such as weight estimates, skull size, bone development, and head size), were analyzed.
resultsThe FGR group exhibited significantly lower EFW (P < 0.001), smaller AC (P < 0.001), shorter femur length (FL) (P < 0.001), and smaller biparietal diameter (BPD) (P < 0.001) compared to the control group. The head circumference to abdominal circumference ratio (HC/AC) was significantly higher in the FGR group (P < 0.001), reflecting abnormal growth patterns. Doppler ultrasound revealed significantly lower velocities and higher resistance indices in both the middle cerebral artery (MCA) and umbilical artery (UA) in the FGR group (P < 0.001). Additionally, biochemical markers such as beta-hCG were significantly higher (P < 0.001), while AFP and PAPP-A were significantly lower in the FGR group (P < 0.001). These findings highlight the importance of using ultrasound and specific biomarkers for effective detection of FGR.
conclusionEarly identification of fetal growth restriction (FGR) using a combination of ultrasound biometric indicators, Doppler blood flow measurements, and biochemical markers significantly enhances diagnostic accuracy, facilitates timely interventions, and enhances both maternal and fetal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.